Published in PLoS One on August 01, 2013
Cardiac excitation-contraction coupling. Nature (2002) 18.48
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol (1985) 10.51
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev (2008) 5.52
Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52
Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem (2011) 2.51
Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res (1999) 2.08
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res (2005) 1.86
Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation (2000) 1.82
Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation (1995) 1.76
Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation (2003) 1.60
Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J (2005) 1.40
Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim (2006) 1.39
The mitochondrial targeting function of randomly generated peptide sequences correlates with predicted helical amphiphilicity. J Biol Chem (1989) 1.38
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res (2006) 1.35
Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res (2010) 1.30
Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem J (2006) 1.23
Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myocytes: implications for cytochrome c oxidase activity. Biochem J (2004) 1.18
Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol (2002) 1.11
Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol (2007) 1.11
Cardiac troponin I is modified in the myocardium of bypass patients. Circulation (2001) 1.09
Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta (2001) 0.99
Standardisation of cardiac troponin I measurement: past and present. Pathology (2010) 0.99
Delta protein kinase C interacts with the d subunit of the F1F0 ATPase in neonatal cardiac myocytes exposed to hypoxia or phorbol ester. Implications for F1F0 ATPase regulation. J Biol Chem (2008) 0.93
Differential loss of cytochrome-c oxidase subunits in ischemia-reperfusion injury: exacerbation of COI subunit loss by PKC-epsilon inhibition. Am J Physiol Heart Circ Physiol (2008) 0.93
Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Clin Chem (1999) 0.89
Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mol Cell Cardiol (2010) 0.88
Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am J Physiol (1997) 0.88
Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin. Vet J (2010) 0.87
Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity. Acta Cardiol (2012) 0.86
Sensitive and high sensitivity next generation cardiac troponin assays: more than just a name. Pathology (2011) 0.86
Targeting the F1Fo ATP Synthase: modulation of the body's powerhouse and its implications for human disease. Curr Med Chem (2011) 0.86
High-sensitive cardiac troponin: friend or foe? Swiss Med Wkly (2011) 0.84
Study of the structure of troponin-T by measuring the relative reactivities of lysines with acetic anhydride. J Mol Biol (1981) 0.83
Role of energy metabolism in the preconditioned heart--a possible contribution of mitochondria. Cardiovasc Res (1999) 0.82
Isolation and characterization of a highly phosphorylated troponin from bovine heart. Eur J Biochem (1988) 0.81
HBOC attenuates intense exercise-induced cardiac dysfunction. Int J Sports Med (2012) 0.81
Release kinetics of cardiac troponin I and cardiac troponin T in effluents from isolated perfused rabbit hearts after graded experimental myocardial contusion. J Trauma (1999) 0.81
Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J Surg Res (1997) 0.80
Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis. Mol Cell Biochem (2005) 0.79
Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency. J Clin Hypertens (Greenwich) (2011) 0.79
Post-conditioning protects from cardioplegia and cold ischemia via inhibition of mitochondrial permeability transition pore. J Heart Lung Transplant (2007) 0.79
Opioid preconditioning: myocardial function and energy metabolism. Ann Thorac Surg (2001) 0.79
Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts. Clin Exp Pharmacol Physiol (2012) 0.79
Degradation of rat cardiac troponin I during ischemia independent of reperfusion. Am J Physiol Heart Circ Physiol (2004) 0.77
Attenuation of the hypoxia-induced protein kinase Cdelta interaction with the 'd' subunit of F1Fo-ATP synthase in neonatal cardiac myocytes: implications for energy preservation and survival. Biochem J (2010) 0.77
Modulation of the protein kinase Cdelta interaction with the "d" subunit of F1F0-ATP synthase in neonatal cardiac myocytes: development of cell-permeable, mitochondrially targeted inhibitor and facilitator peptides. J Biol Chem (2010) 0.77
Kepler-9: a system of multiple planets transiting a Sun-like star, confirmed by timing variations. Science (2010) 2.87
β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing. Circ Res (2013) 1.59
Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem J (2006) 1.23
Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myocytes: implications for cytochrome c oxidase activity. Biochem J (2004) 1.18
Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol (2007) 1.11
Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Circulation (2006) 1.06
Localization, macromolecular associations, and function of the small heat shock-related protein HSP20 in rat heart. Circulation (2003) 0.99
Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.99
Delta protein kinase C interacts with the d subunit of the F1F0 ATPase in neonatal cardiac myocytes exposed to hypoxia or phorbol ester. Implications for F1F0 ATPase regulation. J Biol Chem (2008) 0.93
Differential loss of cytochrome-c oxidase subunits in ischemia-reperfusion injury: exacerbation of COI subunit loss by PKC-epsilon inhibition. Am J Physiol Heart Circ Physiol (2008) 0.93
Adhesive strength of atherosclerotic plaque in a mouse model depends on local collagen content and elastin fragmentation. J Biomech (2012) 0.91
Development of a quantitative mechanical test of atherosclerotic plaque stability. J Biomech (2011) 0.90
Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol (2003) 0.84
Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector. Tissue Eng (2007) 0.84
Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis. J Ethnopharmacol (2012) 0.83
Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay. Can J Microbiol (2010) 0.81
Antimicrobials from the marine algal endophyte Penicillium sp. Nat Prod Commun (2013) 0.79
Isolation and bioassay screening of medicinal plant endophytes from eastern Canada. Can J Microbiol (2013) 0.79
The Canadian medicinal plant Heracleum maximum contains antimycobacterial diynes and furanocoumarins. J Ethnopharmacol (2013) 0.78
Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis. Phytochem Anal (2014) 0.78
Attenuation of the hypoxia-induced protein kinase Cdelta interaction with the 'd' subunit of F1Fo-ATP synthase in neonatal cardiac myocytes: implications for energy preservation and survival. Biochem J (2010) 0.77
Modulation of the protein kinase Cdelta interaction with the "d" subunit of F1F0-ATP synthase in neonatal cardiac myocytes: development of cell-permeable, mitochondrially targeted inhibitor and facilitator peptides. J Biol Chem (2010) 0.77
Epsilon protein kinase C lengthens the quiescent period between spontaneous contractions in rat ventricular cardiac myocytes and trabecula. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.76
Anti-mycobacterial diynes from the Canadian medicinal plant Aralia nudicaulis. J Ethnopharmacol (2012) 0.76
Ubiquitin and ubiquitin-like proteins in cardiac disease and protection. Curr Drug Targets (2015) 0.75
Polyketides from an Endophytic Aspergillus fumigatus Isolate Inhibit the Growth of Mycobacterium tuberculosis and MRSA. Nat Prod Commun (2015) 0.75
Isolation of (-)-avenaciolide as the antifungal and antimycobacterial constituent of a Seimatosporium sp. Endophyte from the medicinal plant Hypericum perforatum . Nat Prod Commun (2014) 0.75
The Impact of Item Characteristics on Item and Scale Validity. Multivariate Behav Res (2004) 0.75
Canadian traditionally used medicinal plants: can they play a role in antituberculosis drug development? Future Med Chem (2013) 0.75
Antimycobacterial Natural Products from Endophytes of the Medicinal Plant Aralia nudicaulis. Nat Prod Commun (2015) 0.75
Preface. Nat Prod Commun (2015) 0.75
Isolation of Phomopsolide A and 6(E)-Phomopsolide A as Antimycobacterial Natural Products from an Unidentified Endophyte of the Canadian Medicinal Plant Heracleum maximum. Nat Prod Commun (2015) 0.75